Skip to main content
MedinCell receives $ 6.4 million grant from Unitaid to fight Malaria
March 25, 2020
US Pharma Development Veteran Dr. Richard Malamut Joins the Medical Advisory Board of MedinCell
January 28, 2020
MedinCell provides a portfolio update for J.P. Morgan Healthcare Conference 2020
January 13, 2020
Publication of the activity report and financial information for the first half-year (April – Sept. 2019)
December 3, 2019
The MedinCell General Meeting votes to include the “Raison d’être” of the Company in its articles of association
September 10, 2019
MedinCell receives a new grant to develop a best-in-class long-acting injectable product for HIV PrEP
September 4, 2019
MedinCell partners to address the untapped financial potential in Animal Health
August 28, 2019
Long-acting injectable antipsychotic using MedinCell’s technology receives FDA IND clearance to initiate clinical activities
August 26, 2019
Publication of the 2018/2019 Annual Financial Report
July 31, 2019
Third long-acting injectable antipsychotic using MedinCell’s technology enters preclinical development
July 9, 2019
